I like SGYP here... Close to a 52wk low - two phase 3 trials reporting this year, ~$200M in cash. Presenting today at the Leerink Global Health Conference at 1:25pm (EST).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.